Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1

Guéguen Paul, Dalekos Georgios, Nousbaum Jean-Baptiste, Zachou Kalliopi, Chaim Putterman, Youinou Pierre, Renaudineau Yves

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of α-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-α-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-α-actinin antibody was found in 21/50 (42%) of AIH-1 patients, compared with 52/401 (12.9%) of liver disease control patients, and with 6/200 (6%) of blood donors. Anti-filamentous and anti-α-actinin activities were found specifically together in 66% of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-α-actinin complex assay, the binding of anti-filamentous actin to α-actinin-binding domain on actin was demonstrated, as well as that of anti-α-actinin on the actin-binding domain of α-actinin. Thus, the frequent combination of anti-filamentous and anti-α-actinin antibodies seems to be the hallmark of activity in AIH-1.

Original languageEnglish (US)
Pages (from-to)495-505
Number of pages11
JournalJournal of Clinical Immunology
Volume26
Issue number6
DOIs
StatePublished - Nov 2006

Fingerprint

Actinin
Autoimmune Hepatitis
Actins
Anti-Idiotypic Antibodies
Blood Donors
Liver Diseases
Epitopes
Western Blotting
Enzyme-Linked Immunosorbent Assay

Keywords

  • Active disease
  • Anti-smooth-muscle antibodies
  • Anti-ssDNA
  • Autoimmunity
  • Binding domain

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1. / Paul, Guéguen; Georgios, Dalekos; Jean-Baptiste, Nousbaum; Kalliopi, Zachou; Putterman, Chaim; Pierre, Youinou; Yves, Renaudineau.

In: Journal of Clinical Immunology, Vol. 26, No. 6, 11.2006, p. 495-505.

Research output: Contribution to journalArticle

Paul, Guéguen ; Georgios, Dalekos ; Jean-Baptiste, Nousbaum ; Kalliopi, Zachou ; Putterman, Chaim ; Pierre, Youinou ; Yves, Renaudineau. / Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1. In: Journal of Clinical Immunology. 2006 ; Vol. 26, No. 6. pp. 495-505.
@article{cca175f3dbfe429fad5c58cb3e9532f1,
title = "Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1",
abstract = "Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of α-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-α-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-α-actinin antibody was found in 21/50 (42{\%}) of AIH-1 patients, compared with 52/401 (12.9{\%}) of liver disease control patients, and with 6/200 (6{\%}) of blood donors. Anti-filamentous and anti-α-actinin activities were found specifically together in 66{\%} of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-α-actinin complex assay, the binding of anti-filamentous actin to α-actinin-binding domain on actin was demonstrated, as well as that of anti-α-actinin on the actin-binding domain of α-actinin. Thus, the frequent combination of anti-filamentous and anti-α-actinin antibodies seems to be the hallmark of activity in AIH-1.",
keywords = "Active disease, Anti-smooth-muscle antibodies, Anti-ssDNA, Autoimmunity, Binding domain",
author = "Gu{\'e}guen Paul and Dalekos Georgios and Nousbaum Jean-Baptiste and Zachou Kalliopi and Chaim Putterman and Youinou Pierre and Renaudineau Yves",
year = "2006",
month = "11",
doi = "10.1007/s10875-006-9045-z",
language = "English (US)",
volume = "26",
pages = "495--505",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Double reactivity against actin and α-actinin defines a severe form of autoimmune hepatitis type 1

AU - Paul, Guéguen

AU - Georgios, Dalekos

AU - Jean-Baptiste, Nousbaum

AU - Kalliopi, Zachou

AU - Putterman, Chaim

AU - Pierre, Youinou

AU - Yves, Renaudineau

PY - 2006/11

Y1 - 2006/11

N2 - Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of α-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-α-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-α-actinin antibody was found in 21/50 (42%) of AIH-1 patients, compared with 52/401 (12.9%) of liver disease control patients, and with 6/200 (6%) of blood donors. Anti-filamentous and anti-α-actinin activities were found specifically together in 66% of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-α-actinin complex assay, the binding of anti-filamentous actin to α-actinin-binding domain on actin was demonstrated, as well as that of anti-α-actinin on the actin-binding domain of α-actinin. Thus, the frequent combination of anti-filamentous and anti-α-actinin antibodies seems to be the hallmark of activity in AIH-1.

AB - Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of α-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-α-actinin enzyme-linked immunosorbent assay was developed, and positivity confirmed by Western blot. Anti-α-actinin antibody was found in 21/50 (42%) of AIH-1 patients, compared with 52/401 (12.9%) of liver disease control patients, and with 6/200 (6%) of blood donors. Anti-filamentous and anti-α-actinin activities were found specifically together in 66% of anti-filamentous-positive AIH-1 patients. This combination of specificities reflected clinical and histological disease activity, short duration and absence of treatment. Finally, using an actin-α-actinin complex assay, the binding of anti-filamentous actin to α-actinin-binding domain on actin was demonstrated, as well as that of anti-α-actinin on the actin-binding domain of α-actinin. Thus, the frequent combination of anti-filamentous and anti-α-actinin antibodies seems to be the hallmark of activity in AIH-1.

KW - Active disease

KW - Anti-smooth-muscle antibodies

KW - Anti-ssDNA

KW - Autoimmunity

KW - Binding domain

UR - http://www.scopus.com/inward/record.url?scp=33751120137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751120137&partnerID=8YFLogxK

U2 - 10.1007/s10875-006-9045-z

DO - 10.1007/s10875-006-9045-z

M3 - Article

VL - 26

SP - 495

EP - 505

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 6

ER -